Rx/Reimbursement Adult Incontinence in Austria

Rx/Reimbursement Adult Incontinence in Austria

Rx/reimbursement adult incontinence recorded strong growth in current value terms in 2023 continuing the trend of the previous year. However, this was mainly due to prevailing inflationary pressures, as rising raw material, production and transport costs forced manufacturers to increase the average unit prices of their products. Indeed, the category saw fairly flat performance in volume terms, as strict regulations continued to dampen demand. In 2021, the Österreichische Gesundheitskasse (Austri...

Euromonitor International's Rx/Reimbursement adult incontinence in Austria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2028 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.